Company intelligence / Profile preview

Evonik Vancouver Laboratories

Burnaby, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Transferra (now Evonik Vancouver Laboratories) is a market leader in lipid nanoparticle development and manufacturing with an unparalleled track record spanning nearly 30 years. The company has developed hundreds of LNP-based formulations and provided CDMO services ranging from early-stage feasibility through commercial manufacturing, including support for COVID-19 vaccine production[6].

Therapeutic areas: OncologyImmunologyOtherInfectious Diseases
Modalities: Lipid nanoparticle delivery therapyNanoparticle
Industry: Drug Discovery Services

Partnerships

Customers include pharmaceutical and biotechnology companies globallyPartners utilized various rapid-mixing technologies for nucleic acid LNPs

Beyond the preview

Go deeper on Evonik Vancouver Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evonik Vancouver Laboratories.

Explore the full profile